Screener

Eligibility screening

Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel

Sponsored by Iovance Biotherapeutics, Inc.Study detailsClinicalTrials.gov

3 US sites in CO, NC, TN

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.